Материалы

17.08.2016

Presepsin acurately predicts mortality in patients undergoing transcatheter aortic valve implantation (TAVI)

Objective: The aim of this study was to assess whether Presepsin, a novel marker indicative for sepsis, has prognostic value in the postoperative outcome in patients after transcatheter aortic valve implantation (TAVI).

Яндекс.Метрика